ReviewPharmacological research2024

IUPHAR review - Glucagon-like peptide-1 (GLP-1) and substance use disorders: An emerging pharmacotherapeutic target.

Nicolaus Bruns Vi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.